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Secondary lymphoid tissues such as lymph nodes are essential for the interactions
between antigen presenting cells and lymphocytes that result in adaptive immune
responses that protect the host against invading pathogens. The specialized architecture
of these organs facilitates the cognate interactions between antigen-loaded dendritic cells
and lymphocytes expressing their speciﬁc receptor as well as B–T cell interactions that
are at the core of long lasting adaptive immune responses. Lymph nodes develop during
embryogenesis as a result of a series of cross-talk interactions between a hematopoietically
derived cell lineage called lymphoid tissue inducer cells and stromal cells of mesenchymal
origin to form the anlagen of these organs. This review will present an overview of the
different signaling pathways and maturation steps that mesenchymal cells undergo during
the process of lymph node formation such as cell speciﬁcation, priming, and maturation to
become lymphoid tissue stromal organizer cells.
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Lymph nodes (LN) develop during embryogenesis in mice and
humans following a precise timing depending on anatomi-
cal location. Mesenteric LNs develop ﬁrst in mouse embryos
around embryonic day (E) 10.5, followed by the rest of these
organs along the anterior-posterior body axis (Rennert et al.,
1996, 1998; Mebius, 2003). Vertebrate organogenesis results
from complex interactions of molecular and cellular networks
in which progenitor cells become speciﬁed, proliferate and dif-
ferentiate to ascertain organ formation and function (Brendolan
et al., 2007; Costantini and Kopan, 2010). These sequential
events are orchestrated by signaling molecules that activate cell-
speciﬁc gene expression programs in uncommitted progenitors
(Dressler, 2009). Thus, it is conceivable that LN development
relies on similar mechanisms for the acquisition of cellular iden-
tity (speciﬁcation) and that uncommitted mesenchymal cells
assume a LN fate prior to proliferation and formation of the
anlagen. Once speciﬁed, mesenchymal cells engage in cross-
talk with lymphoid cells and this assures LN expansion coupled
to mesenchymal cell differentiation (Roozendaal and Mebius,
2011). Two central cellular players required for the develop-
ment of secondary lymphoid tissues during mouse embryoge-
nesis have been identiﬁed (Honda et al., 2001; Mebius, 2003;
Nishikawa et al., 2003). Lymphoid tissue inducer (LTi) cells,
derived from lymphoid cell precursors and belonging to the
family of innate lymphoid cells and mesenchymal progeni-
tors cells whose origin have not been elucidated yet. LTi cells
express CD45, CD4, interleukin-7 receptor α, integrin α4β7,
receptor activator of NF-κB (RANK/TRANCE-R) and its lig-
and RANKL/TRANCE, lymphotoxin α1β2 (LT1β2), and the
chemokine receptor CXCR5 and thus are attracted in response
to the chemokine CXC-chemokine ligand 13 (CXCL13) secreted
by mesenchymal cells.
Conversely, mesenchymal cells have been characterized as
CD45−, PDGF-receptor α+, lymphotoxin β receptor+ (LTβR),
vascular cell adhesion molecule-1 (VCAM-1−), and intercellular
adhesion molecule-1 (ICAM-1−). Analysis of different knockout
mouse models has led to the discovery of several genes required for
LN development and revealed a multistep process in which inter-
actions between LTi cells and mesenchymal cells appear crucial to
assure organ formation. However, the origin and identity of the
signals that induce the speciﬁcation of mesenchymal progenitor
cells prior to the arrival of LTi cells at the site of LN formation
remain largely unknown.
Lymphoid tissue inducer cell numbers appear to be the limiting
factor controlling the development of LNs and other secondary
lymphoid tissues as shown by the fact that over-expression of IL-7
in vivo, results in a signiﬁcant increase of LTi cells and the number
of LN (Meier et al., 2007).
MESENCHYMAL CELL SPECIFICATION
The mechanisms governing the spatial and temporal organiza-
tion of the different LNs are poorly understood. It is currently
unclear which signals assure LN organogenesis to take place at
deﬁne locations along the body axis and ensure mesenchymal cell
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FIGURE 1 | Model of lymph node development. Step 1: Retinoic Acid
produced by neurons stimulates mesenchymal cells to express the
chemokine CXCL13. Step 2: CXCL13 expression by mesenchymal cells
attracts lymphoid tissue inducer (LTi) cells to the site where lymph nodes
will develop. LTi cells will cluster and they might signal in trans to each
other through RANKL-RANK. Step 3: RANK signaling on LTi cells will induce
high expression levels of LTα1β2. Binding of the latter to LTβR on
mesenchymal cells will induce the expression of cell adhesion molecules
VCAM-1, ICAM-1, and MAdCAM-1 as well as CXCL13, CCL21, and CCL19
to initiate a positive feedback loop that will attract large numbers of LTi
cells to the LN anlage and thus result in the formation of the structure the
organs.
speciﬁcation prior to the clustering of LTi cells at sites where these
organs will develop.
Given the different location of LNs along the antero-posterior
axis, it is likely that different signals are required to commit pro-
genitor cells toward a LN fate for each speciﬁc set of organs.
Expression of CXCL13 by mesenchymal cells appears to be the
ﬁrst sign of mesenchymal cell speciﬁcation (van de Pavert et al.,
2009; Figure 1, step 1). This chemokine is required for the initial
recruitment of LTi cells to form clusters with the former at the
sites of LN formation (Ansel et al., 2000; Luther et al., 2003; Ohl
et al., 2003). Recent work has shown that retinoic acid (RA) from
neuronal cells induces CXCL13 expression in mesenchymal cells,
indicating a possible role for RA in specifying, at least in part,
the LN-mesenchyme (van de Pavert et al., 2009). These results
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suggest a mechanism for speciﬁcation of mesenchymal cells and
for their initial condensation to form the LN anlagen that is LTi
cell-independent. While RA was shown to induce CXCL13 expres-
sion in the mesenchymal LN anlage, it is presently unknown
whether this morphogen has a similar action in the presumptive
mesenchymal cells at the site of all LNs or different speciﬁcation
signals exist depending on the location of the organs. Cxcl13−/−
and Cxcr5−/− embryos fail to form most LN anlagen due to the
inability of recruiting LTi cells, yet mesenteric and cervical LNs are
present in adult Cxcl13−/− mice, and Cxcr5−/− embryos develop
rudimentary LN anlage (Ansel et al., 2000; Ohl et al., 2003). How-
ever, the ﬁnding that speciﬁcation of mesenchymal cells can occur
even in the absence of CXCL13 argues in favor of other signals
required for this process.
Given the pleiotropic role of RA during vertebrate develop-
ment including its capacity to regulate cell-fate and differentiation
(Niederreither and Dolle, 2008), if RA derived from neuronal cells
is required for specifying the mesenchymal cells of most LN, it is
likely that, in addition to CXCL13, it activates a set of downstream
targets including Hox genes (Wang et al., 2006; Duester, 2008).
Hox genes encode a family of homeodomain transcription factors
required for organ patterning and cell fate speciﬁcation along the
antero-posterior axis during embryogenesis thus they represent
candidate factors involved in patterning the early LN anlage. It has
been shown that the mature counterpart of the mesenchymal cells
that form the LN anlage, lymphoid tissue organizer (LTo) cells
from mesenteric LNs and Peyer’s patches express different Hox
genes (Okuda et al., 2007).
A century ago, Sabin (1902, 1909) identiﬁed a series of struc-
tures in pig embryos named lymph sacs from which it was
hypothesized that LN develop. In support of this hypothesis is
the recent ﬁnding that lymph sacs form during inguinal LN for-
mation through endothelial-cell budding from the vasculature. It
was proposed that invasion of the endothelial lumen by the sur-
rounding mesenchyme will form the LN anlagen (Benezech et al.,
2010). However, Vondenhoff et al. (2009b) have shown that in
mouse embryos lacking lymphatic vasculature due to conditional
ablation of Prox1 in endothelial cells (Tie2-Cre; Prox1f /f ) the LN
anlage still forms, although it is associated with hypoplasia and
reduced number of LTi cells. While these ﬁndings indicate that
lymphatic endothelial cells and lymph sacs may not be required
for positioning LTi cells at the site of organ formation, they do
not exclude a role for the lymphatic endothelium in specifying the
surrounding mesenchyme. Thus, loss of lymphatic signals may
affect the ability of mesenchymal cells to become fully speciﬁed
and to attract a critical number of LTi cells at the site of LN anlage
formation and this scenario may also explain the LN hypoplasia
observed in Prox1−/− mice.
At present, however, despite a possible role of RA in the
speciﬁcation of mesenchymal progenitors, the source of the
signals and the transcriptional program that ensures full com-
mitment of progenitor cells into LN mesenchymal cells remains
unknown.
LYMPH NODE ANLAGE FORMATION AND EXPANSION
Following mesenchymal cell speciﬁcation and clustering of LTi
cells, a series of cross-talk interactions between these cell
populations appear to be crucial to assure organ development
(Figure 1, step 2). Clustering of LTi cells expressing both
RANK-L and its receptor RANK in the developing LN anlagen
suggest that the RANK-L/RANK signaling pathway might be acti-
vated in trans by the close proximity of these cells (Kim et al.,
2000; Vondenhoff et al., 2009a). RANK signaling up-regulates the
expression of LTα1β2 thus enhancing the cross-talk interactions
between LTi cells and the mesenchymal precursor cells (Yoshida
et al., 2002; Vondenhoff et al., 2009a). A putative function for
RANK signaling in LN stromal cells has been recently indi-
cated (Hess et al., 2012; Sugiyama et al., 2012). Analysis of the
CD45− cell population in mesenteric and inguinal LN of E14
mouse embryos onward shows the presence of newly speciﬁed
mesenchymal cells that are negative for VCAM-1 and ICAM-
1 expression but positive for PDGFRα. By E15.5 these V−I−
mesenchymal precursors differentiate into VCAM-1Int ICAM-
1Int PDGFRα+ “primed” mesenchymal cells independently of
the presence of LTi cells as accumulation of this intermedi-
ate population is present in Rorc−/− and Ltβr−/− embryonic
LNs (Benezech et al., 2010). Importantly, the signal/s that prime
the V− I− progenitors to become Vint Iint mesenchymal cells
remains to be identiﬁed. By E17.5 primed Vint Iint mesenchy-
mal cells differentiate into Vhigh Ihigh MAdCAM-1+ LTo cells
(Figure 1, step 3). This maturation step requires LT signal-
ing and LTi cells as LTo cells are absent in the LN anlagen of
Ltbr−/− and Rorc−/− mice (lacking LTi cells). Accumulation
of LTi cells in the LN anlagen coincides with the differentiation
of Vint Iint mesenchymal cells into VhighIhigh MAdCAM-1+ LTo
cells (Cupedo et al., 2004b; Cupedo and Mebius, 2005; Benezech
et al., 2010).
The tumor necrosis factor (TNF) family ligand LTα1β2
expressed on LTi cells engages its receptor, LTβR on Vint Iint mes-
enchymal cells, resulting in the activation of the NF-κB family
of transcription factors through the classical/canonical (NF-κB1
p50/RelA) and the alternative/non-canonical pathways (NF-κB2
p52/RelB; Dejardin et al., 2002; Yilmaz et al., 2003). This pro-
cess leads to increased expression of ICAM-1 and VCAM-1 and
the homeostatic chemokines CXCL13, CCL19, and CCL21 cre-
ating a positive feedback loop for the continuous recruitment
and retention of LTi cells and for the proliferation and home-
ostasis of LTo cells (Randall et al., 2008; Ruddle and Akirav, 2009;
van de Pavert and Mebius, 2010). Interestingly, while the three
stromal cell populations present in LN anlagen (V−I−, Vint Iint,
VhighIhigh) express LTβR, the NF-κB member RelB is only detected
in Vint Iint, and VhighIhigh cells correlating with their higher lev-
els of expression of chemokines and cell adhesion molecules with
respect to theV−I− cell population (Benezech et al., 2010). Lack of
LTβR signaling in LTo cells, as observed in Ltα−/−, Ltβr−/−, and
Rorc−/− mice, results in the absence of all LNs (De Togni et al.,
1994; Futterer et al., 1998; Sun et al., 2000; Eberl and Littman,
2003; Eberl et al., 2004; White et al., 2007; Benezech et al., 2010).
Relb−/− mice also fail to develop all LNs and Nfkb2−/− mice
present with poorly developed inguinal and popliteal LNs due
to impaired expression of chemokines, cell adhesion molecules
and development of high endothelial venules (Weih and Caa-
maño, 2003; Carragher et al., 2004). Similarly, mice carrying a
phosphorylation mutant kinase IKKα, that is essential for the
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activation of the NF-κB alternative pathway, have a similar LN
phenotype than the Nfkb2−/− mice (Drayton et al., 2004). LTβR
signaling is required for the maturation and homeostasis of LTo
cells and for expression of RANK-L, MAdCAM-1, and lympho-
organogenic chemokines (Yoshida et al., 2002; Eberl et al., 2004;
Coles et al., 2006; White et al., 2007; Vondenhoff et al., 2009a;
Benezech et al., 2010).
LN ORGAN EXPANSION AND LT ORGANIZER CELL
DIFFERENTIATION
Lymphoid tissue organizer cells are thought to represent the
precursors of mature stromal cells in adult LN. However, the con-
tribution of the former to the stromal cell subsets in adult organs
and the signals that induce their differentiation are still poorly
deﬁned.
Previouswork showed that transplantation of neonatal LN cells
under the skin of adult mice gave rise to distinct stromal cell
networks, thus indicating that neonatal LTo cells from the trans-
planted cell suspensions were capable to differentiate into mature
stromal cells (Cupedo et al., 2004a). Importantly depletion of LTi
cells from the neonatal LN cell populations impaired their ability
to develop an ectopic lymphoid structure in this system. Despite
that these ﬁndings indicate that neonatal LN contains stromal
progenitors, lineage-tracing experiments are required to unequiv-
ocally demonstrate the precursor-product relationship between
embryonic LTo cells and adult LN stromal cells, including follicu-
lar dendritic cells as previously suggested (Katakai et al., 2008). In
addition, it also needs to be determined whether the different stro-
mal cell subsets originate from single multipotent mesenchymal
progenitors or whether distinct progenitors exist for each stromal
cell subpopulation.
MARGINAL RETICULAR CELLS
Lymphoid tissue organizer cells and marginal reticular cells
(MRCs) are similar in the expression of several markers suggesting
a precursor-product relationship between these cell types (Katakai
et al., 2008; Roozendaal and Mebius, 2011), although formal proof
that LTo cells can generate MRCs is still lacking. MRCs are located
under the subcapsular sinus of LNs and in the spleen marginal
zone where they are referred as marginal sinus lining cells. These
stromal cells express MAdCAM-1, CXCL13, VCAM-1, ICAM-
1, BP3, and RANK-L and their maturation does not appear to
depend on signals from T- or B-cells as Rag2−/− mice have an
intact LN MRC layer (Katakai et al., 2008). However, blocking
LTβR signaling causes loss of CXCL13 and MAdCAM-1 expres-
sion on MRCs thus indicating that engagement of the LT pathway,
possibly by LTi cells or their adult counterpart is required for
maintaining the phenotypic characteristics of these cells. A recent
report has shown that over-expression of RANK-L has an effect
on MRCs and other stromal and endothelial cell types in adult
LN resulting in enhance cell proliferation and organ expansion
with increase numbers of B-cell follicles (Hess et al., 2012). Con-
versely, blocking of RANK-L in mouse embryos appears to disrupt
B-cell follicle formation and induce HEV maturation in newborn
mice (Sugiyama et al., 2012). In addition, differentiation of MRC
appears to be strictly connected to signals associated to the devel-
opment of secondary lymphoid organs since these cells are not
found in ectopic lymphoid tissues and tertiary lymphoid organs
(Katakai et al., 2008).
FOLLICULAR DENDRITIC CELLS
Follicular dendritic cells (FDCs) localize in the center of the B-
cell follicle and appear a week after birth. Several studies have
proposed a mesenchymal origin for FDCs although it is currently
unclear whether FDCs arise from in situ embryonic mesenchymal
precursors or from cells migrating to the organ postnatally (Allen
and Cyster, 2008; e.g., bone marrow).
Recent studies show that FDCs originate fromperivascular pro-
genitor cells expressing Mfge8 and Pdgfrb genes and that ablation
of PDGFRβ+ cells induces the collapse of FDC networks. In addi-
tion, these ﬁndings also showed that PDGFRβ+ perivascular cells
from non-lymphoid organs have the capacity to differentiate into
FDCs in vitro and in vivo, thus suggesting that this cell population
may be the source of FDC in tertiary lymphoid organ formation
(Krautler et al., 2012). B-cell derived signals are required for FDC
maturation as demonstrated by mice deﬁcient for TNFα, LTα1β2
and their receptors that fail to develop FDCnetworks and germinal
centers (Allen and Cyster, 2008).
FIBROBLASTIC RETICULAR CELLS
Fibroblastic reticular cells (FRCs) are a heterogeneous popu-
lation of stromal cells distributed in the T-zone of secondary
lymphoid organs (Mueller and Germain, 2009). FRCs form the
conduit system, a network of collagen-rich channels surrounded
by ﬁbroblasts that allows small molecules, such as chemokines
and antigens to reach the T cell zones (Sixt et al., 2005; Bajenoff
et al., 2006). Contrary to the spleen in which the formation of
the FRC network depends on LTα1β2 from B-cells, LNs FRC
networks develop normally in the absence of B-cells (Ngo et al.,
2001), thus indicating that different signaling molecules and cell
types may be required for proper FRC differentiation in different
lymphoid organs. At present, it remains unclear whether FRCs
originate from a common embryonic mesenchymal progenitor
or if different lineages of mesenchymal cells generate the FRC
network.
CONCLUDING REMARKS
Over the past several years, novel ﬁndings have highlighted
the complexity of the cellular and molecular mechanisms gov-
erning lymphoid organ development and function. Central to
these ﬁndings is the notion that interactions between lymphoid
and mesenchymal cells are crucial for the development of sec-
ondary lymphoid organs. However, the cellular and molecular
events underlying LN regionalization and those implicated in
mesenchymal cell speciﬁcation remain largely undeﬁned.
It is also unknown at what point during lineage diversiﬁcation
mesenchymal cells become fully committed toward a speciﬁc fate
and whether distinct stromal cell subsets arise from single multi-
potent progenitors or if different precursors exists for each stromal
cell type. Despite these developmentally unsolved questions,
recent work by several groups has shown that stromal cells are
not merely passive inhabitants of lymphoid organs as previously
thought, but instead are active players in modulating the activity
of the immune system by providing structural support and signals
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for survival, attraction, locomotion, and activation of immune
cells (Mueller and Germain, 2009). The recent discovery that some
stromal cell subsets contribute to tolerance induction further high-
lights their important function in the homeostasis of immune
system (Fletcher et al., 2011). Thus, a full understanding of the
ontogeny and function of the stromal microenvironment still
requires that we uncover the genetic and transcriptional programs
underlying mesenchymal cell differentiation and elucidate the
molecular repertoire that characterize each stromal subsets during
normal and pathological conditions.
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